新型生物标志物与银屑病相关的心血管风险。 - Suppr | 超能文献

相似文献

1

Novel biomarkers and psoriasis associated cardiovascular risk.新型生物标志物与银屑病相关的心血管风险。

Arch Dermatol Res. 2024 May 2;316(5):140. doi: 10.1007/s00403-024-02891-8.

2

Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?银屑病与动脉粥样硬化：是否需要新型生物标志物来评估心血管风险？

Curr Pharm Des. 2014;20(4):529-35. doi: 10.2174/138161282004140213124141.

3

GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.糖化白蛋白是银屑病炎症和亚临床心血管疾病的新型生物标志物。

Circ Res. 2016 Nov 11;119(11):1242-1253. doi: 10.1161/CIRCRESAHA.116.309637. Epub 2016 Sep 21.

4

Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk.根据七种风险评估算法，银屑病面积和严重程度指数（PASI）≥10%所描述的中重度斑块状银屑病可能与更高的心血管风险相关：一项为期10年的单中心回顾性研究结果及伴有心血管风险的银屑病患者的临床管理。

Dermatol Ther. 2020 Nov;33(6):e14451. doi: 10.1111/dth.14451. Epub 2020 Nov 14.

5

Discordance between estimated cardiovascular risk and subclinical atherosclerosis in psoriasis: when seeing helps believing.银屑病患者估计的心血管风险与亚临床动脉粥样硬化之间的不一致：眼见为实。

Eur J Prev Cardiol. 2022 Mar 30;29(4):588-590. doi: 10.1093/eurjpc/zwaa041.

6

Regional Variation in Cardiovascular Risk Factor Screening by Dermatologists for Psoriasis Patients in the United States.美国皮肤科医生对银屑病患者进行心血管危险因素筛查的地区差异。

J Invest Dermatol. 2023 Sep;143(9):1816-1819. doi: 10.1016/j.jid.2023.03.1655. Epub 2023 Mar 27.

7

Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.心血管问题的考虑因素及对银屑病治疗的影响：最新综述。

Vasc Health Risk Manag. 2024 May 10;20:215-229. doi: 10.2147/VHRM.S464471. eCollection 2024.

8

Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis.综合脂质四分位数指数、致动脉粥样硬化指数与脂质过氧化：银屑病中心血管风险增加的替代标志物

Indian J Dermatol Venereol Leprol. 2015 Sep-Oct;81(5):464-71. doi: 10.4103/0378-6323.163734.

9

Malondialdehyde, lipoprotein-a, lipoprotein ratios, comprehensive lipid tetrad index and atherogenic index as surrogate markers for cardiovascular disease in patients with psoriasis: a case-control study.丙二醛、脂蛋白-a、脂蛋白比值、综合脂质四联指数和致动脉粥样硬化指数作为银屑病患者心血管疾病的替代标志物：病例对照研究。

Arch Dermatol Res. 2019 May;311(4):287-297. doi: 10.1007/s00403-019-01896-y. Epub 2019 Mar 4.

10

Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis.体重减轻对肥胖银屑病患者心血管风险状况的影响。

Acta Derm Venereol. 2014 Nov;94(6):691-4. doi: 10.2340/00015555-1824.

引用本文的文献

1

Residual metabolic burden in young psoriasis patients successfully treated with biologics.生物制剂成功治疗后年轻银屑病患者的残留代谢负担。

Arch Dermatol Res. 2024 Sep 27;316(9):647. doi: 10.1007/s00403-024-03403-4.

本文引用的文献

1

Association of the triglyceride glucose index with insulin resistance and subclinical atherosclerosis in psoriasis: An observational cohort study.银屑病中甘油三酯葡萄糖指数与胰岛素抵抗及亚临床动脉粥样硬化的关联：一项观察性队列研究。

J Am Acad Dermatol. 2023 May;88(5):1131-1134. doi: 10.1016/j.jaad.2022.08.027. Epub 2022 Aug 19.

2

Endothelial Dysfunction in Psoriasis: An Updated Review.银屑病中的内皮功能障碍：最新综述

Front Med (Lausanne). 2022 Jun 10;9:864185. doi: 10.3389/fmed.2022.864185. eCollection 2022.

3

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.